L1 Capital International Strategy Trimmed HCA Healthcare (HCA) Due to Share Price Appreciation

1 hour ago 2

Soumya Eswaran

Thu, January 15, 2026 astatine 7:57 AM CST 3 min read

L1 Capital, an concern absorption firm, released its “L1 Capital International Fund” (unhedged) fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The Strategy focuses connected investing successful high-quality companies with favorable cashflow-based valuations. The missive highlighted the existent concern environment, the Fund’s positioning, portfolio adjustments, and the quarterly (December) and yearly (2025) review. The steadfast considers valuation investigation indispensable for imaginable AI-focused investments; simply having condemnation successful AI isn't capable to guarantee a palmy concern outcome. In general, 2025 was a beardown twelvemonth for each banal markets globally. The money returned 2.2%, nett of fees, compared to 2.5% for the benchmark (MSCI World Net Total Return Index successful AUD). For the year, the money returned 9.8% (net of fees) compared to 12.4% for the Index. In addition, you tin cheque the Strategy’s apical 5 holdings to cognize its champion picks successful 2025.

In its fourth-quarter 2025 capitalist letter, L1 Capital International Fund highlighted stocks specified arsenic HCA Healthcare, Inc. (NYSE:HCA). HCA Healthcare, Inc. (NYSE:HCA) owns and operates hospitals and related healthcare entities. On January 14, 2026, HCA Healthcare, Inc. (NYSE:HCA) banal closed astatine $478.84 per share. One-month instrumentality of HCA Healthcare, Inc. (NYSE:HCA) was 2.63%, and its shares gained 54.74% of their worth implicit the past 52 weeks. HCA Healthcare, Inc. (NYSE:HCA) has a marketplace capitalization of $109.38 billion.

L1 Capital International Fund stated the pursuing regarding HCA Healthcare, Inc. (NYSE:HCA) successful its 4th fourth 2025 capitalist letter:

"At the commencement of 2025, the marketplace was acutely acrophobic that healthcare argumentation nether President Trump and the Republicans would importantly negatively interaction backstage hospitals and outpatient work providers specified arsenic HCA Healthcare, Inc. (NYSE:HCA) compared to operating conditions since Obamacare and nether President Biden. As outlined successful the December 2024 Quarterly Report, during this play of overly antagonistic sentiment we were expanding our concern successful HCA and it became 1 of the Fund’s largest holdings. While determination person been immoderate adverse regulatory developments, the One Big Beautiful Bill Act besides had respective provisions that benefited HCA. Today, expectations for operating conditions are much balanced. HCA’s stock terms accrued 55% during 2025 and we person progressively reduced the HCA position, with HCA present being 1 of the smallest Fund holdings."

Mizuho Sees Improving Margins Supporting HCA Healthcare into 2026

Mizuho Sees Improving Margins Supporting HCA Healthcare into 2026

HCA Healthcare, Inc. (NYSE:HCA) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 73 hedge money portfolios held HCA Healthcare, Inc. (NYSE:HCA) astatine the extremity of the 3rd quarter, the aforesaid arsenic successful the erstwhile quarter. While we admit the imaginable of HCA Healthcare, Inc. (NYSE:HCA) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.


Read Entire Article